Insulet Corporation News Releases http://investors.insulet.com/ Insulet Corporation News Releases en Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes http://investors.insulet.com/news-releases/news-release-details/insulets-omnipodr-horizontm-hybrid-closed-loop-system-improves Pediatric Scientific Data for the Omnipod Horizon System Presented at the American Diabetes Association’s 79 th Scientific Sessions ACTON, Mass. --(BUSINESS WIRE)--Jun. 9, 2019-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump  technology with its Sun, 09 Jun 2019 21:30:00 -0400 Insulet Corporation News Releases 15816 Insulet to Showcase its Recently-Launched Omnipod® DASH™ System and Present Seven Scientific Abstracts at the American Diabetes Association's 79th Scientific Sessions http://investors.insulet.com/news-releases/news-release-details/insulet-showcase-its-recently-launched-omnipodr-dashtm-system No-Cost Personal Diabetes Manager, No Four Year Lock-in Period, and New User Interface Allow for Smooth Transition from Multiple Daily Injections (MDI) to Pod Therapy ACTON, Mass. --(BUSINESS WIRE)--Jun. 6, 2019-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless Thu, 06 Jun 2019 06:00:00 -0400 Insulet Corporation News Releases 15811 Insulet to Present at Upcoming Investor Conferences http://investors.insulet.com/news-releases/news-release-details/insulet-present-upcoming-investor-conferences-2 ACTON, Mass. --(BUSINESS WIRE)--May 16, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 2019 UBS Global Thu, 16 May 2019 06:00:00 -0400 Insulet Corporation News Releases 15706 Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year http://investors.insulet.com/news-releases/news-release-details/insulet-reports-first-quarter-2019-revenue-1596-million-increase Commenced Pod Production at U.S. Manufacturing Facility and Initiated Full U.S. Commercial Launch of Omnipod DASH ™ ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Thu, 02 May 2019 16:01:00 -0400 Insulet Corporation News Releases 15681 Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA http://investors.insulet.com/news-releases/news-release-details/insulet-celebrates-new-global-headquarters-and-us-manufacturing Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation  (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod Thu, 02 May 2019 06:00:00 -0400 Insulet Corporation News Releases 15676 Insulet to Announce First Quarter 2019 Financial Results on May 2, 2019 http://investors.insulet.com/news-releases/news-release-details/insulet-announce-first-quarter-2019-financial-results-may-2-2019 ACTON, Mass. --(BUSINESS WIRE)--Apr. 4, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2019 on  Thu, 04 Apr 2019 06:00:00 -0400 Insulet Corporation News Releases 15636 Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22% http://investors.insulet.com/news-releases/news-release-details/insulet-reports-fourth-quarter-2018-revenue-1649-million-26-year ACTON, Mass. --(BUSINESS WIRE)--Feb. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for the three months and full year Mon, 25 Feb 2019 16:01:00 -0500 Insulet Corporation News Releases 15451 Insulet to Present at Upcoming Investor Conferences http://investors.insulet.com/news-releases/news-release-details/insulet-present-upcoming-investor-conferences-1 ACTON, Mass. --(BUSINESS WIRE)--Feb. 19, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: The Raymond James Tue, 19 Feb 2019 16:01:00 -0500 Insulet Corporation News Releases 15391 Insulet Appoints Corinne Nevinny to Board of Directors http://investors.insulet.com/news-releases/news-release-details/insulet-appoints-corinne-nevinny-board-directors ACTON, Mass. --(BUSINESS WIRE)--Jan. 28, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Corinne Nevinny has been appointed to the Company’s Mon, 28 Jan 2019 16:01:00 -0500 Insulet Corporation News Releases 15326 Insulet to Announce Fourth Quarter and Full Year 2018 Financial Results on February 25, 2019 http://investors.insulet.com/news-releases/news-release-details/insulet-announce-fourth-quarter-and-full-year-2018-financial ACTON, Mass. --(BUSINESS WIRE)--Jan. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full Fri, 25 Jan 2019 08:30:00 -0500 Insulet Corporation News Releases 15316